Global X China Biotech Innovation ETF (CHB)
Global X China Biotech Innovation ETF (CHB) reported 44 holdings in its SEC Form NPORT-P for the period ended 2023-11-30.
No stock price history for CHB on this site yet.
SEC Form NPORT-P as filed (series S000069671), accession 0001752724-24-017795.
Similar ETFs
| ETF Name | Country | Net Assets | Overlap |
|---|---|---|---|
| ETFMG Treatments Testing and Advancements ETF (GERM) | 3.56% | ||
| Defiance Nasdaq Junior Biotechnology ETF (IBBJ) | 2.30% | ||
| Virtus Biotech Etf (BBP) | United States | $0.059B | 1.94% |
| Tema Oncology ETF (CANC) | United States | $0.160B | 1.46% |
| Loncar China BioPharma ETF (CHNA) | 1.44% | ||
| ALPS Medical Breakthroughs ETF (SBIO) | United States | $0.138B | 1.39% |
| Invesco China Small Cap ETF (HAO) | 1.07% | ||
| abrdn World Healthcare Fund (THW) | United States | 0.93% | |
| Fidelity Disruptive Medicine ETF (FMED) | United States | $0.061B | 0.77% |
| First Trust Chindia ETF (FNI) | 0.56% |